腎細胞癌機理研究:從RhoA透過微小核酸群調控CD44表現到生物標記及治療之研發(1/3)

Pharmacology, Toxicology and Pharmaceutical Science

1. Benzyloxycarbonylleucylleucylleucinal 5%
2. Biological Marker 100%
3. Calpeptin 5%
4. Carcinogen 5%
5. Carcinogenesis 5%
6. Combination Therapy 5%
7. Cycloheximide 5%
8. Dactinomycin 5%
9. Dioxins and Dioxin-Like Compounds 5%
10. Fibronectin 5%
11. Histone Deacetylase 1 11%
12. Histone Deacetylase Inhibitor 5%
13. Kidney Tumour 5%
14. Luciferase 5%
15. Methylcholanthrene 5%
16. microRNA 100%
17. Mouse Model 11%
18. Neoplasm 5%
19. Nerve Cell Adhesion Molecule 5%
20. Neutralizing Antibody 5%
21. Nude Mouse 11%
22. Renal Cell Carcinoma 100%
23. Simvastatin 11%
24. Survival Rate 5%
25. Vimentin 5%
26. Vorinostat 5%

Immunology and Microbiology

1. Agonist 18%
2. Carcinoma Cell 100%
3. CD44 100%
4. Cell Invasion 6%
5. Cell Migration 6%
6. Cell Proliferation 6%
7. Dactinomycin 6%
8. Dioxins and Dioxin-Like Compounds 6%
9. DNA Microarray 6%
10. Epithelial Mesenchymal Transition 12%
11. Fibronectin 6%
12. Mouse Model 12%
13. Neural Cell Adhesion Molecule 6%
14. Neutralizing Antibody 6%
15. Nude Mouse 12%
16. Renal Cell Carcinoma Cell Line 6%
17. Survival Rate 6%
18. Upregulation 6%
19. Xenograft 12%